Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. (Q54550455)

31 May 2018

title

Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. (English)

1 reference

31 May 2018

7

Mary B Daly

1 reference

31 May 2018

author name string

Xiaowei Chen

1

1 reference

31 May 2018

Joellen Weaver

2

1 reference

31 May 2018

Betsy A Bove

3

1 reference

31 May 2018

Lisa A Vanderveer

4

1 reference

31 May 2018

Susan C Weil

5

1 reference

31 May 2018

Alexander Miron

6

1 reference

31 May 2018

Andrew K Godwin

8

1 reference

31 May 2018

publication date

19 January 2008

1 reference

31 May 2018

published in

Human Molecular Genetics

1 reference

31 May 2018

volume

17

1 reference

31 May 2018

issue

9

1 reference

31 May 2018

page(s)

1336-1348

1 reference

31 May 2018

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Growth retardation and tumour inhibition by BRCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Quantification of single nucleotide polymorphisms: a novel method that combines primer extension assay and capillary electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Allele-specific gene expression differences in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Overexpression of BRCA2 gene in sporadic breast tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

BRCA2 mutations in primary breast and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

BRCA1 promoter deletions in young women with breast cancer and a strong family history: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:psiBRCA1 recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

A somatic mutation in the 5'UTR of BRCA1 gene in sporadic breast cancer causes down-modulation of translation efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

MicroRNAs direct rapid deadenylation of mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Prevalence of BRCA mutations and founder effect in high-risk Hispanic families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

The frequent BRCA1 mutation 1135insA has multiple origins: a haplotype study in different populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Allelic Variation in Human Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: Public health implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

Small changes in expression affect predisposition to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDN022

21 January 2018

Identifiers

DOI

10.1093/HMG/DDN022

1 reference

31 May 2018

PubMed ID

18204050

1 reference

31 May 2018